Clinical Characteristics of Lymphatic Malformations
Clinical Characteristics of Lymphatic Malformations: An Observational Study
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
Sichuan
-
Chengdu, Sichuan, China, 610041
- West China Hospital of Sichuan University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- The investigators enrolled participants who were pathologically diagnosed with lymphangioma or lymphatic malformations in the abdominal cavity (i.e., abdominal lymphatic malformations) from January 2009 to December 2022 at our institution.
Exclusion Criteria:
- The investigators excluded participants without a pathological diagnosis of abdominal lymphatic malformations through resection specimens and those with pathological confirmation of other diseases, as well as patients with complex lymphatic anomalies.
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Paediatric group
The investigators defined participants under 14 years old as the paediatric group.
|
Compare the epidemiological characteristics, clinical presentations, surgical treatments and risk factors for preoperative complications of ALMs between paediatric and adult participants.
|
|
Adult group
The investigators defined participants over 14 years old as the adult group.
|
Compare the epidemiological characteristics, clinical presentations, surgical treatments and risk factors for preoperative complications of ALMs between paediatric and adult participants.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The location of abdominal lymphatic malformations in participants
Time Frame: From 2009.1 to 2022.12
|
Location included mesentery, retroperitoneum, omentum, spleen, etc.
|
From 2009.1 to 2022.12
|
|
The morphologic subtypes of abdominal lymphatic malformations in participants
Time Frame: From 2009.1 to 2022.12
|
Morphologic subtypes included macrocystic, microcystic and mixed type.
|
From 2009.1 to 2022.12
|
|
The presentations at diagnosis of abdominal lymphatic malformations in participants
Time Frame: From 2009.1 to 2022.12
|
Presentations at diagnosis included chronic pain, acute abdominal disease and incidental health checkup.
|
From 2009.1 to 2022.12
|
|
The largest diameter of abdominal lymphatic malformations in participants
Time Frame: From 2009.1 to 2022.12
|
Largest diameter in centimeters was mainly measured by intraoperative detections.
|
From 2009.1 to 2022.12
|
|
The preoperative complications of abdominal lymphatic malformations in participants
Time Frame: From 2009.1 to 2022.12
|
Preoperative complications included intestinal volvulus, haemorrhage, infection, rupture and compression.
|
From 2009.1 to 2022.12
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The incidence of abdominal lymphatic malformations in paediatric and adult group
Time Frame: From 2009.1 to 2022.12
|
Incidence of abdominal lymphatic malformations in paediatric and adult group was retrospectively compared.
|
From 2009.1 to 2022.12
|
|
The number of female patients with abdominal lymphatic malformations in paediatric and adult group
Time Frame: From 2009.1 to 2022.12
|
Number of female patients with abdominal lymphatic malformations in paediatric and adult group was retrospectively compared.
|
From 2009.1 to 2022.12
|
|
The rate of abdominal lymphatic malformations with acute abdomen in paediatric and adult group
Time Frame: From 2009.1 to 2022.12
|
Rate of abdominal lymphatic malformations with acute abdomen in paediatric and adult group was retrospectively compared.
|
From 2009.1 to 2022.12
|
|
The rate of abdominal lymphatic malformations located in mesentery for paediatric and adult group
Time Frame: From 2009.1 to 2022.12
|
Rate of abdominal lymphatic malformations located in mesentery for paediatric and adult group was retrospectively compared.
|
From 2009.1 to 2022.12
|
|
The risk factors of preoperative complications of abdominal lymphatic malformations for paediatric and adult group.
Time Frame: From 2009.1 to 2022.12
|
Risk factors of preoperative complications of abdominal lymphatic malformations for paediatric and adult group was retrospectively compared.
|
From 2009.1 to 2022.12
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Yi Ji, Ph.D., West China Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2024-127
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.